TRIMTECH Therapeutics raised $31M in a seed funding round led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund to advance targeted protein degradation for neurodegenerative diseases.
Amount Raised
$31 Million
Round Type
Seed
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
TRIMTECH Therapeutics announced the closing of its $31 million seed funding round to support the development of its pipeline for treating neurodegenerative diseases. This investment was led by notable investors including Cambridge Innovation Capital and SV Health Investors.
Quick answer
TRIMTECH Therapeutics raised $31 Million in a Seed round, dated March 5, 2025. Investors: MP Healthcare Venture Management, Eli Lilly And Company, Pfizer Ventures, M Ventures, Cambridge Enterprise Ventures, Start Codon, SV Health Investors' Dementia Discovery Fund and Cambridge Innovation Capital. TRIMTECH Therapeutics is based in Cambridge, England, United Kingdom.
- How much did TRIMTECH Therapeutics raise?
- TRIMTECH Therapeutics raised $31 Million in a Seed round on March 5, 2025.
- Who invested in TRIMTECH Therapeutics?
- MP Healthcare Venture Management, Eli Lilly And Company, Pfizer Ventures, M Ventures, Cambridge Enterprise Ventures, Start Codon, SV Health Investors' Dementia Discovery Fund and Cambridge Innovation Capital are named as investors in this round.
- What does TRIMTECH Therapeutics do?
- TRIMTECH Therapeutics is a biotech company focused on harnessing targeted protein degradation for the treatment of neurodegenerative diseases.
- Where is TRIMTECH Therapeutics based and how big is it?
- TRIMTECH Therapeutics is based in Cambridge, England, United Kingdom. Fundz records about 21 employees.
- Who are the decision-makers at TRIMTECH Therapeutics?
- Fundz holds 2 contacts at TRIMTECH Therapeutics, including the SVP Head of Chemistry. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as TRIMTECH Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $283M on April 17, 2025.
- Lobe Sciences raised $6M (Series A) on April 14, 2025.
- Decoy Therapeutics raised $1.2M (Seed) on April 11, 2025.
- OncoNano Medicine raised $13M on April 11, 2025.
- Merida Therapeutics raised $121M (Series A) on April 8, 2025.
- Accure Therapeutics S.L raised $1.6M (Seed) on April 7, 2025.
Who to call at TRIMTECH Therapeutics, and when
A new round usually means TRIMTECH Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TRIMTECH Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TRIMTECH Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TRIMTECH Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TRIMTECH Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TRIMTECH Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.